Girgis MS, Weintraub MA, Almanand JP, Chang ET, Malik RE, Dluzniewski P
The newly released clinical trial data comes on the heels of another study published in July that found Mounjaro, which also has tirzepatide as its main active ingredient, was more effective for weight loss than Ozempic, whose main active ingredient is semaglutide
Combined with concerning reviews and a high cost for questionable value , many people may end up paying more for a supplement that doesnt deliver clinically backed weight loss support
are co-founders of Ousia Pharma, a biotech company developing therapeutics for treatment of obesity
Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment
Is retatrutide safe for long-term use